Cipher Pharmaceuticals, Inc. (NASDAQ: CPHR) is a dermatology company committed to offering healthcare professionals products that will better address their patients’ needs and enrich their practices. As such, the company’s innovative dermatology products provide efficacy, flexibility and convenience across a range of skin conditions. In 2015, the company has so far completed seven transactions to build out its U.S. commercial infrastructure, and to expand and strengthen its presence in Canada. By 2020, it plans to launch two new first-to-the-market products and increase its market capitalization to $1 billion. For more information, visit the company’s website at www.cipherpharma.com.